Compounds > risedronic acid
Page last updated: 2024-08-16

risedronic acid and ne 10790

risedronic acid has been researched along with ne 10790 in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baron, R; Coxon, F; Dunford, JE; Ebetino, FH; Kashemirov, BA; Marma, MS; McKenna, CE; Russell, RG; Stewart, C; Triffitt, JT; Xia, Z1
Barnett, BL; Dunford, JE; Ebetino, FH; Kavanagh, KL; Kwaasi, AA; Oppermann, U; Rogers, MJ; Russell, RG1
Bala, JL; Baron, RA; Błazewska, KM; Coxon, FP; Dunford, JE; Ebetino, FH; Kashemirov, BA; Kirsten, ML; Lundy, MW; Mallard-Favier, I; Marma, MS; McKenna, CE; Rogers, MJ; Rojas, J; Seabra, MC; Stewart, CA1
Allen, C; Born, EJ; Holstein, SA; Wiemer, DF; Zhou, X1

Other Studies

4 other study(ies) available for risedronic acid and ne 10790

ArticleYear
Synthesis and biological evaluation of alpha-halogenated bisphosphonate and phosphonocarboxylate analogues of risedronate.
    Journal of medicinal chemistry, 2007, Nov-29, Volume: 50, Issue:24

    Topics: Alkyl and Aryl Transferases; Animals; Bone Density Conservation Agents; Cell Line; Cell Proliferation; Cell Survival; Chromatography, Liquid; Diphosphonates; Durapatite; Etidronic Acid; Geranyltranstransferase; Mice; Organophosphonates; Propionates; Protein Prenylation; Pyridines; Risedronic Acid; Structure-Activity Relationship

2007
Structure-activity relationships among the nitrogen containing bisphosphonates in clinical use and other analogues: time-dependent inhibition of human farnesyl pyrophosphate synthase.
    Journal of medicinal chemistry, 2008, Apr-10, Volume: 51, Issue:7

    Topics: Binding Sites; Diphosphonates; Enzyme Inhibitors; Geranyltranstransferase; Humans; Models, Molecular; Molecular Structure; Nitrogen; Stereoisomerism; Structure-Activity Relationship; Time Factors

2008
Synthesis, chiral high performance liquid chromatographic resolution and enantiospecific activity of a potent new geranylgeranyl transferase inhibitor, 2-hydroxy-3-imidazo[1,2-a]pyridin-3-yl-2-phosphonopropionic acid.
    Journal of medicinal chemistry, 2010, May-13, Volume: 53, Issue:9

    Topics: Alkyl and Aryl Transferases; Bone Density Conservation Agents; Bone Resorption; Cell Line; Cell Survival; Chromatography, High Pressure Liquid; Enzyme Inhibitors; Etidronic Acid; Humans; Lactates; Organophosphonates; Organophosphorus Compounds; Osteoporosis; Protein Prenylation; rab GTP-Binding Proteins; Risedronic Acid; Stereoisomerism

2010
N-Oxide derivatives of 3-(3-pyridyl)-2-phosphonopropanoic acids as potential inhibitors of Rab geranylgeranylation.
    Bioorganic & medicinal chemistry letters, 2015, Jun-01, Volume: 25, Issue:11

    Topics: Alkyl and Aryl Transferases; Cell Line, Tumor; Drug Discovery; Humans; Molecular Structure; Multiple Myeloma; Propionates; Structure-Activity Relationship

2015